open access
The influence of treatment with quinapril on arterial stiffness, blood viscosity and arterial shear stress among patients with essential hypertension
open access
Abstract
Material and methods 55 patients, aged 52.8 ± 13.8 yrs. with HT 1 and 2 st. were treated with quinapril 10 mg/d. If BP was above 140/90 mmHg the dose of quinapril was increased up to 40 mg/d. at 3 month visit. At baseline and then after 3 and 6 months of treatment PWV, WBV, proMMP-1 and TIMP-1 were determined. Shear stress in AA and (CCA) was calculated from WBV, internal vessel diameter and blood flow velocity (Vmax) measured ultrasonographically.
Results After 6 months treatment with quinapril significant decrease was observed in BP (155.6/92.0 mm Hg vs. 135.9/82.9 mm Hg, p < 0.001), PWV (10.35 m/s vs. 9.64 ms, p < 0.001), WBV (5.14 cP vs. 4.86 cP, p < 0.05) and TIMP-1 (111.0 ng/ml vs. 94.1 ng/ml, p < 0.001). In the same period increased: Vmax in AA (127.1 cm/s vs. 131.3 cm/s, p < 0.05, Vmax in CCA (69.9 cm/s vs. 78.4 cm/s, p < 0.05), shear stress in CCA (22.2 dyne/cm2 vs. 24.7 dyne/ /cm2, p < 0.05 ). Significant positive correlation was observed between PWV and TIMP-1, and negative correlations between PWV and Vmax in AA, PWV and Vmax in CCA, as well as PWV and shear stress in CCA.
Conclusions Quinapril improves blood rheology and reduces arterial stiffness by inhibition of collagen metabolism. The effect on arterial stiffness seems to be secondary to increase of arterial shear stress.
Abstract
Material and methods 55 patients, aged 52.8 ± 13.8 yrs. with HT 1 and 2 st. were treated with quinapril 10 mg/d. If BP was above 140/90 mmHg the dose of quinapril was increased up to 40 mg/d. at 3 month visit. At baseline and then after 3 and 6 months of treatment PWV, WBV, proMMP-1 and TIMP-1 were determined. Shear stress in AA and (CCA) was calculated from WBV, internal vessel diameter and blood flow velocity (Vmax) measured ultrasonographically.
Results After 6 months treatment with quinapril significant decrease was observed in BP (155.6/92.0 mm Hg vs. 135.9/82.9 mm Hg, p < 0.001), PWV (10.35 m/s vs. 9.64 ms, p < 0.001), WBV (5.14 cP vs. 4.86 cP, p < 0.05) and TIMP-1 (111.0 ng/ml vs. 94.1 ng/ml, p < 0.001). In the same period increased: Vmax in AA (127.1 cm/s vs. 131.3 cm/s, p < 0.05, Vmax in CCA (69.9 cm/s vs. 78.4 cm/s, p < 0.05), shear stress in CCA (22.2 dyne/cm2 vs. 24.7 dyne/ /cm2, p < 0.05 ). Significant positive correlation was observed between PWV and TIMP-1, and negative correlations between PWV and Vmax in AA, PWV and Vmax in CCA, as well as PWV and shear stress in CCA.
Conclusions Quinapril improves blood rheology and reduces arterial stiffness by inhibition of collagen metabolism. The effect on arterial stiffness seems to be secondary to increase of arterial shear stress.
Keywords
arterial hypertension; quinapril; arterial stiffness; blood viscosity; shear stress; prometalloproteinase-1; metalloproteinase-1 tissue inhibitor
About this articleTitle
The influence of treatment with quinapril on arterial stiffness, blood viscosity and arterial shear stress among patients with essential hypertension
Journal
Issue
Article type
Original paper
Pages
182-189
Published online
2008-05-29
Page views
562
Article views/downloads
1067
Bibliographic record
Nadciśnienie tętnicze 2008;12(3):182-189.
Keywords
arterial hypertension
quinapril
arterial stiffness
blood viscosity
shear stress
prometalloproteinase-1
metalloproteinase-1 tissue inhibitor
Authors
Marek Rajzer
Wiktoria Wojciechowska
Marek Klocek
Małgorzata Brzozowska-Kiszka
Kalina Kawecka-Jaszcz